Abstract/Details

STAT6 expression in glioblastoma promotes invasive growth


2011 2011

Other formats: Order a copy

Abstract (summary)

Signal Transducers and Activators of Transcription (STATs) were initially identified as modulators of the immune response, but more recently have been ascribed numerous roles in the regulation of carcinogenesis, tumor maintenance and tumor progression. Reports indicate that STATs 3, 5A and 5B play important roles in the regulation of GBM pathophysiology. In this study, we investigated the expression, activation status and physiological effects of STAT6 in glioblastoma (GBM), and correlated its expression with patient survival.

First, we utilized GBM cell lines and human patient tissue specimens to demonstrate increased STAT6 expression relative to non-malignant cells and normal brain tissue at the protein and mRNA level by Western blot, immunohistochemistry and real-time (quantitative) PCR. Next, we assessed the effects of lentiviral STAT6 knockdown by shRNA on the proliferation and invasion of two STAT6-positive GBM cell lines. STAT6-deficient GBM cells showed a reduction in 3H-Thymidine uptake compared to the wild-type, ranging from 35%–70% in U-1242MG and 40–50% in U-87MG cells. Additionally, STAT6-depleted cells were less invasive than controls in our in vitro transmembrane invasion assay. Invasiveness was decreased by 25–40% and 30–75% in U-1242MG and U-87MG cells, respectively. A microarray analysis comparing wild type U-87MG and U-1242MG to their respective STAT6 knockdown clones identified several potential downstream mediators of STAT6 signaling.

We utilized the National Cancer Institute (NCI) Rembrandt public data depository (NCI, 2005) to generate Kaplan-Meyer survival curves showing the relationship between STAT6 gene expression and survival times for glioma patients. In a dataset of 343 glioma patients—including grades II–IV (GBM)—there was a significant difference in survival (p < 0.05) between patients with up- and down-regulated STAT6 (NCI, 2005). Decreased STAT6 expression correlated with longer survival times. When patient data was separated into lower grade gliomas and GBM (grade IV), a similar but non-significant trend was observed.

Taken together, these findings suggest a role for STAT6 in enhancing cell proliferation and invasion in GBM, which may explain why up-regulation of STAT6 correlates with shorter survival times in glioma patients. This report thus identifies STAT6 as a new and potentially promising therapeutic target.

Indexing (details)


Subject
Molecular biology;
Oncology
Classification
0307: Molecular biology
0992: Oncology
Identifier / keyword
Health and environmental sciences, Biological sciences, Glioblastoma, Invasive growth, STAT6
Title
STAT6 expression in glioblastoma promotes invasive growth
Author
Merk, Barbara Christine
Number of pages
135
Publication year
2011
Degree date
2011
School code
0246
Source
DAI-B 72/11, Dissertation Abstracts International
Place of publication
Ann Arbor
Country of publication
United States
ISBN
9781124891941
Advisor
Hussaini, Isa
University/institution
University of Virginia
University location
United States -- Virginia
Degree
Ph.D.
Source type
Dissertations & Theses
Language
English
Document type
Dissertation/Thesis
Dissertation/thesis number
3475688
ProQuest document ID
893140485
Copyright
Database copyright ProQuest LLC; ProQuest does not claim copyright in the individual underlying works.
Document URL
http://search.proquest.com/docview/893140485
Access the complete full text

You can get the full text of this document if it is part of your institution's ProQuest subscription.

Try one of the following:

  • Connect to ProQuest through your library network and search for the document from there.
  • Request the document from your library.
  • Go to the ProQuest login page and enter a ProQuest or My Research username / password.